Home

mahmuz tolerans Fide event free survival overall leukemie uzuvlar Kakadu Çaba göster

Survival analysis in hematologic malignancies: recommendations for  clinicians | Haematologica
Survival analysis in hematologic malignancies: recommendations for clinicians | Haematologica

Kaplan-Meier overall survival (OS) and event-free survival (EFS)... |  Download Scientific Diagram
Kaplan-Meier overall survival (OS) and event-free survival (EFS)... | Download Scientific Diagram

New and emerging prognostic and predictive genetic biomarkers in B-cell  precursor acute lymphoblastic leukemia | Haematologica
New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia | Haematologica

Overall survival and event-free survival according to primary... | Download  Scientific Diagram
Overall survival and event-free survival according to primary... | Download Scientific Diagram

Relapses and treatment-related events contributed equally to poor prognosis  in children with ABL-class fusion positive B-cell acute lymphoblastic  leukemia treated according to AIEOP-BFM protocols | Haematologica
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols | Haematologica

Event-free survival (EFS) curves for children with acute lymphoblastic... |  Download Scientific Diagram
Event-free survival (EFS) curves for children with acute lymphoblastic... | Download Scientific Diagram

A) Overall survival and (B) event-free survival of 58 patients with... |  Download Scientific Diagram
A) Overall survival and (B) event-free survival of 58 patients with... | Download Scientific Diagram

A) Overall survival (OS) and (B) eventfree survival (EFS) for patients... |  Download Scientific Diagram
A) Overall survival (OS) and (B) eventfree survival (EFS) for patients... | Download Scientific Diagram

Pharmacogenetic Analysis of Pediatric Patients with Acute Lymphoblastic  Leukemia: A Possible Association between Survival Rate and ITPA  Polymorphism | PLOS ONE
Pharmacogenetic Analysis of Pediatric Patients with Acute Lymphoblastic Leukemia: A Possible Association between Survival Rate and ITPA Polymorphism | PLOS ONE

Enrolling children with acute lymphoblastic leukaemia on a clinical trial  improves event-free survival: a population-based study | British Journal of  Cancer
Enrolling children with acute lymphoblastic leukaemia on a clinical trial improves event-free survival: a population-based study | British Journal of Cancer

Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in  Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's  Oncology Group Trial AAML0531 | Journal of Clinical Oncology
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531 | Journal of Clinical Oncology

Kaplan–Meier Estimates of Event-free and Overall Survival among... |  Download Scientific Diagram
Kaplan–Meier Estimates of Event-free and Overall Survival among... | Download Scientific Diagram

Treatment response, survival, safety, and predictive factors to chimeric  antigen receptor T cell therapy in Chinese relapsed or refractory B cell  acute lymphoblast leukemia patients | Cell Death & Disease
Treatment response, survival, safety, and predictive factors to chimeric antigen receptor T cell therapy in Chinese relapsed or refractory B cell acute lymphoblast leukemia patients | Cell Death & Disease

The Kaplan–Meier analysis of 5-year event-free survival and overall... |  Download Scientific Diagram
The Kaplan–Meier analysis of 5-year event-free survival and overall... | Download Scientific Diagram

View Image
View Image

Cancers | Free Full-Text | Real-World Outcomes of Patients with Refractory  or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML  Registry Study | HTML
Cancers | Free Full-Text | Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study | HTML

Successes and challenges in the treatment of pediatric acute myeloid  leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012  | Leukemia
Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012 | Leukemia

Improved Outcomes of All-trans-retinoic Acid and Arsenic Trioxide Plus  Idarubicin as a Frontline Treatment in Adult Patients With Acute  Promyelocytic Leukemia - ScienceDirect
Improved Outcomes of All-trans-retinoic Acid and Arsenic Trioxide Plus Idarubicin as a Frontline Treatment in Adult Patients With Acute Promyelocytic Leukemia - ScienceDirect

Event-free survival, cumulative incidence of relapse and overall... |  Download Scientific Diagram
Event-free survival, cumulative incidence of relapse and overall... | Download Scientific Diagram

Event-free survival of childhood acute promyelocytic leukemia (APL)... |  Download Scientific Diagram
Event-free survival of childhood acute promyelocytic leukemia (APL)... | Download Scientific Diagram

Interpretation of clinical endpoints in trials of acute myeloid leukemia -  ScienceDirect
Interpretation of clinical endpoints in trials of acute myeloid leukemia - ScienceDirect

The effect of adopting pediatric protocols in adolescents and young adults  with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT  Cohort study - Gupta - 2019 - Cancer Medicine - Wiley Online Library
The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study - Gupta - 2019 - Cancer Medicine - Wiley Online Library

Ivosidenib + azacitidine ups event-free survival in IDH1-mutated acute  myeloid leukemia
Ivosidenib + azacitidine ups event-free survival in IDH1-mutated acute myeloid leukemia

Kaplan–Meyer estimate of overall survival (OS) and event-free survival... |  Download Scientific Diagram
Kaplan–Meyer estimate of overall survival (OS) and event-free survival... | Download Scientific Diagram

The 5-year Kaplan-Meier overall survival (K-M OS) (A) and event-free... |  Download Scientific Diagram
The 5-year Kaplan-Meier overall survival (K-M OS) (A) and event-free... | Download Scientific Diagram